Catamaran USA : Holds Annual and Special Meeting of Shareholders

SCHAUMBURG, IL, May 14, 2015 /PRNewswire/ - Catamaran Corporation (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology solutions, is pleased to announce that at its annual and special meeting of shareholders held on May 12, 2015, each of the nine nominees listed in its management information circular dated April 1, 2015 was elected as a director. The detailed results of the voting are as follows:

    Nominee           Votes For             % For        Votes Withheld           % Withheld
    -------           ---------             -----        --------------           ----------

    Peter J. Bensen             137,091,286       99.82%                  246,872            0.18%

    Steven D. Cosler            136,842,265       99.64%                  495,893            0.36%

    William J. Davis            137,093,943       99.82%                  244,215            0.18%

    Steven B. Epstein           136,832,025       99.63%                  506,133            0.37%

    Betsy Holden                136,085,262       99.09%                1,252,896            0.91%

    Karen Katen                 135,037,855       98.33%                2,300,303            1.67%

    Harry M. Kraemer            136,340,814       99.27%                  997,344            0.73%

    Anthony R. Masso            137,094,905       99.82%                  243,253            0.18%

    Mark A. Thierer             134,794,549       98.15%                2,543,709            1.85%

In addition to the election of the Company's nine directors, the Company's shareholders re-appointed KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2015, and approved, on an advisory basis, the compensation of the Company's named executive officers. The Company's shareholders did not ratify an amendment to the Company's bylaws to include advance notice and certain other requirements for shareholders to propose director nominations or other business for shareholder meetings.

About Catamaran

Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 400 million prescriptions each year on behalf of 35 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Schaumburg, Ill., with multiple locations in the U.S. and Canada. For more information, please visit CatamaranRx.com, and for industry news and information, follow Catamaran on Twitter, @CatamaranCorp.

For more information, please contact:
Tony Perkins
Investor Relations
Catamaran
Tel: [phone]
[e-mail]

SOURCE Catamaran